Salt Iodization: Meeting the Needs of Pregnancy, Lactation and Infancy (SIMPLIFY)

April 18, 2016 updated by: Maria Andersson, Swiss Federal Institute of Technology

Salt Iodization and the 1st 1000 Days: Does a USI Program Cover the Iodine Requirement of Pregnant and Lactating Women and Infants?

The purpose of this study is to determine whether universal salt iodization (USI) meets the iodine requirements of pregnant women, lactating women and infants.

Study Overview

Status

Completed

Conditions

Detailed Description

Because pregnant women, lactating women and infants are the groups most vulnerable to iodine deficiency and its irreversible consequences, programs should focus on these groups. But like other mass fortification strategies, it is uncertain whether USI can meet the increased dietary requirements of pregnant women, lactating women and infants. Objective of this study to test whether USI can meet the dietary requirements of iodine in women of reproductive age, pregnant women, lactating women and infants up to 2 years of age without causing excess iodine intake in school children and non-pregnant non-lactating women. The study hypothesis is that USI, when fortified at adequate levels and applied to all salt consumed, including both household salt and salt used for processed foods, provides adequate dietary iodine for all population groups, except for weaning infants; while not posing any risk of excessive iodine intakes in other age groups.

Study Type

Observational

Enrollment (Actual)

8000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanxi
      • Linfen, Shanxi, China, 041000
        • Shanxi Institute for Prevention and Treatment of Endemic Disease
      • Zagreb, Croatia, 10000
        • University of Zagreb
      • Manila, Philippines
        • University of Santo Tomas Hospital
      • Zurich, Switzerland, 8092
        • ETH Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 weeks to 44 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

In each of the four study countries, six population groups will be studied:

  • women of reproductive age
  • pregnant women
  • lactating women
  • young infants
  • toddlers
  • school-aged children

Description

Inclusion Criteria:

  • living at study area for at least 6 months
  • generally healthy
  • no chronic medication
  • no history of thyroid disease in the family
  • no use of iodine containing dietary supplements during the last 6 months
  • no use of iodine containing disinfectants for the last 6 months
  • no use of X-ray / CT contrast agent or iodine containing medication within the last year
  • in addition for women of reproductive age, pregnant women and breastfeeding women: age between 18 and 44 years old
  • in addition for pregnant women: healthy pregnancy, singleton pregnancy (no twins or multiple pregnancy)
  • in addition for breastfeeding women and breastfed infants: healthy pregnancy, singleton pregnancy (no twins or multiple pregnancy), baby born at full-term (in pregnancy week 38 to 42), the baby had normal birth weight (≥ 2500 g), baby not older than 6 months, baby currently completely breastfed (except for water, tea and juices)
  • in addition for toddlers: between 6 and 24 months old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Women of reproductive age
Age: 18-44 years
Pregnant women
Age: 18-44 years
Lactating women
Age: 18-44 years
Young infants
Age: younger than 6 months
Toddlers
Age: between 6 and 24 months
School-aged children
Age: 6-12 years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urinary iodine concentration (µg/L)
Time Frame: 1 day
Participants will be assessed only once. However, for 30% of the study participants urinary iodine concentration will be assessed in spot samples collected on two different days, spread over an expected average of 5 days.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thyroglobulin (µg/L)
Time Frame: 1 day
Thyroglobulin will be measured in all population groups
1 day
Breast milk iodine concentration (µg/L)
Time Frame: 1 day
Breast milk iodine concentration will be measured in lactating women.
1 day

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thyroid function (TSH, T4)
Time Frame: 1 day
Thyroid function (TSH, T4) will be measured where relevant.
1 day
Urinary sodium excretion (mg/day)
Time Frame: 1 day
Urinary sodium excretion will be assessed in school age children and women of reproductive age. Participants will be assessed only once. However, for urinary sodium excretion 30% of the study participants will be assessed in spot samples collected on two different days, spread over an expected average of 5 days
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

June 2, 2014

First Submitted That Met QC Criteria

July 18, 2014

First Posted (Estimate)

July 22, 2014

Study Record Updates

Last Update Posted (Estimate)

April 19, 2016

Last Update Submitted That Met QC Criteria

April 18, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • EK 2013-N-82

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iodine Deficiency

3
Subscribe